WHERE THE BRIGHTEST MINDS in health and IT meet.

Precision Medicine: Harnessing Biomedical Data to Improve the Prediction, Prevention, Diagnosis and Treatment of Disease

February 20, 2017 — 03:00PM - 04:00PM EST
Orange County Convention Center
Hall F4
Session ID: 
61

Description

Precision medicine represents a new frontier whose goal is to provide the best available care for each patient through personalized care. Through the use of evidence-based medicine, it is an emerging approach for disease treatment and prevention, as well as research and development to accelerate biomedicine using very large sets of health and disease-related data linked to individual patients to collect and link genotypic, phenotypic and lifestyle data. Tools employed can include molecular diagnostics, imaging and analytics and software. Next-generation genomic technologies allow clinicians and biomedical researchers to drastically increase the amount of genomic data collected on large study populations. When combined with new informatics approaches that enable access and integrate many kinds of data with genomic data in disease research, researchers are able to better understand the genetic bases of drug response and disease.

Learning Objectives: 

  • Describe how emerging technologies, tools and platforms for precision medicine are driving scientific discovery for treatment and prevention of disease
  • Recognize how to leverage and engage with leading health data infrastructure initiatives such as TOPMed, FDA Sentinel and PCORnet
  • Analyze the value of NHLBI’s large population cohort studies for advancing health IT partnerships to enhance assessment of at-risk patients, developing improved options for treatment and prevention
  • Identify the opportunities and challenges for advancing research and population health through integrating biomedical and clinical research data with other rich sources of data (e.g., claims data)
  • Discuss factors supporting sustainable collaborations amongst researchers, health providers and industry for advancing the potential of precision medicine

Audience: 

Life Sciences Professionals
Government or Public Policy Professional
C-Suite

Level: 

Intermediate

WHERE THE BRIGHTEST MINDS

in health and IT meet.

JOIN US